MGNX - MacroGenics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
91,185
151,941
75,643
97,764
62,024
Cost of revenue
6,540
7,384
2,651
-
-
Gross profit
84,645
144,557
72,992
-
-
Operating expenses
Research development
217,226
207,026
214,577
193,201
195,309
Selling general and administrative
60,860
58,949
63,014
42,742
46,064
Total operating expenses
276,282
265,975
275,787
228,824
239,209
Operating income or loss
-191,637
-121,418
-202,795
-131,060
-177,185
Total other income/expenses net
1,055
1,660
680
1,321
25,374
Income before tax
-190,582
-119,758
-202,115
-129,739
-151,811
Income from continuing operations
-190,582
-119,758
-202,115
-129,739
-151,811
Net income
-190,582
-119,758
-202,115
-129,739
-151,811
Net income available to common shareholders
-190,582
-119,758
-202,115
-129,739
-151,811
Basic EPS
-
-1.95
-3.37
-2.47
-3.16
Diluted EPS
-
-1.95
-3.37
-2.47
-3.16
Basic average shares
-
61,433
59,945
52,442
48,083
Diluted average shares
-
61,433
59,945
52,442
48,083
EBITDA
-
-121,418
-202,795
-131,060
-166,340